Skip to main content
. Author manuscript; available in PMC: 2019 Aug 2.
Published in final edited form as: Toxicol Pathol. 2013 Feb 19;41(8):1093–1105. doi: 10.1177/0192623313477256

Figure 4.—

Figure 4.—

Aflatoxin B1 (AFB1) induced proliferation foci in liver after repeated-dose treatment. 75 μg/kg AFB1 treatment induced formation of proliferation focus after 4-week (A) and 5-week (B) treatment (arrow). The altered foci were characteristic of clear cytoplasm and many cells have a centrally located nucleus (clear cell foci). Bars represent 50 μm.